816 related articles for article (PubMed ID: 24462240)
21. Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis.
Ohkawa T; Satake S; Yokoi N; Miyazaki Y; Ohshita T; Sobue G; Takashima H; Watanabe O; Fukata Y; Fukata M
J Neurosci; 2014 Jun; 34(24):8151-63. PubMed ID: 24920620
[TBL] [Abstract][Full Text] [Related]
22. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
Armangue T; Spatola M; Vlagea A; Mattozzi S; Cárceles-Cordon M; Martinez-Heras E; Llufriu S; Muchart J; Erro ME; Abraira L; Moris G; Monros-Giménez L; Corral-Corral Í; Montejo C; Toledo M; Bataller L; Secondi G; Ariño H; Martínez-Hernández E; Juan M; Marcos MA; Alsina L; Saiz A; Rosenfeld MR; Graus F; Dalmau J;
Lancet Neurol; 2018 Sep; 17(9):760-772. PubMed ID: 30049614
[TBL] [Abstract][Full Text] [Related]
23. Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression.
Triplett J; Vijayan S; MacDonald A; Lawn N; McLean-Tooke A; Bynevelt M; Phatouros C; Chemmanam T
J Neuroimmunol; 2018 Oct; 323():119-124. PubMed ID: 30196824
[TBL] [Abstract][Full Text] [Related]
24. The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies.
van Coevorden-Hameete MH; de Bruijn MAAM; de Graaff E; Bastiaansen DAEM; Schreurs MWJ; Demmers JAA; Ramberger M; Hulsenboom ESP; Nagtzaam MMP; Boukhrissi S; Veldink JH; Verschuuren JJGM; Hoogenraad CC; Sillevis Smitt PAE; Titulaer MJ
Brain; 2019 Jun; 142(6):1631-1643. PubMed ID: 31009048
[TBL] [Abstract][Full Text] [Related]
25. Treatment responsive GABA(B)-receptor limbic encephalitis presenting as new-onset super-refractory status epilepticus (NORSE) in a deployed U.S. soldier.
Hainsworth JB; Shishido A; Theeler BJ; Carroll CG; Fasano RE
Epileptic Disord; 2014 Dec; 16(4):486-93. PubMed ID: 25465280
[TBL] [Abstract][Full Text] [Related]
26. GABA
Menke AF; Ismail FS; Dornmair K; Cerina M; Meuth SG; Melzer N
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409067
[TBL] [Abstract][Full Text] [Related]
27. GABAA receptor encephalitis associated with human parvovirus B19 virus infection: Case report.
Valle DAD; Santos MLSF; Spinosa MJ; Telles BA; Prando C; Cordeiro ML
Medicine (Baltimore); 2021 Jun; 100(23):e26324. PubMed ID: 34115048
[TBL] [Abstract][Full Text] [Related]
28. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients.
Höftberger R; Titulaer MJ; Sabater L; Dome B; Rózsás A; Hegedus B; Hoda MA; Laszlo V; Ankersmit HJ; Harms L; Boyero S; de Felipe A; Saiz A; Dalmau J; Graus F
Neurology; 2013 Oct; 81(17):1500-6. PubMed ID: 24068784
[TBL] [Abstract][Full Text] [Related]
29. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.
Lai M; Huijbers MG; Lancaster E; Graus F; Bataller L; Balice-Gordon R; Cowell JK; Dalmau J
Lancet Neurol; 2010 Aug; 9(8):776-85. PubMed ID: 20580615
[TBL] [Abstract][Full Text] [Related]
30. Autoimmunity, seizures, and status epilepticus.
Davis R; Dalmau J
Epilepsia; 2013 Sep; 54 Suppl 6(0 6):46-9. PubMed ID: 24001072
[TBL] [Abstract][Full Text] [Related]
31. Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA
Brändle SM; Cerina M; Weber S; Held K; Menke AF; Alcalá C; Gebert D; Herrmann AM; Pellkofer H; Gerdes LA; Bittner S; Leypoldt F; Teegen B; Komorowski L; Kümpfel T; Hohlfeld R; Meuth SG; Casanova B; Melzer N; Beltrán E; Dornmair K
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619082
[TBL] [Abstract][Full Text] [Related]
32. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates.
Ances BM; Vitaliani R; Taylor RA; Liebeskind DS; Voloschin A; Houghton DJ; Galetta SL; Dichter M; Alavi A; Rosenfeld MR; Dalmau J
Brain; 2005 Aug; 128(Pt 8):1764-77. PubMed ID: 15888538
[TBL] [Abstract][Full Text] [Related]
33. GAD65-Ab encephalitis and subtle focal status epilepticus.
Goudot M; Frismand S; Hopes L; Verger A; Joubert B; Honnorat J; Tyvaert L
Epileptic Disord; 2019 Oct; 21(5):437-442. PubMed ID: 31649008
[TBL] [Abstract][Full Text] [Related]
34. Anti-GABA-A Receptor Antibody-Mediated Epilepsia Partialis Continua After Treatment With Alemtuzumab: A Case Report.
Ratuszny D; Skripuletz T; Stüber T; Valizada E; Gehring K; Ertl P; Müller JA; Wattjes MP; Feuerhake F; Sühs KW
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37202183
[TBL] [Abstract][Full Text] [Related]
35. Investigation of anti-neuronal antibodies in status epilepticus of unknown etiology: a prospective study.
Atmaca MM; Tuzun E; Erdag E; Bebek N; Baykan B; Gurses C
Acta Neurol Belg; 2017 Dec; 117(4):841-848. PubMed ID: 28547540
[TBL] [Abstract][Full Text] [Related]
36. Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study.
Bozzetti S; Rossini F; Ferrari S; Delogu R; Cantalupo G; Marchioretto F; Zanette G; Zanoni T; Turatti M; Vitale G; Cadaldini M; Rossi F; Di Tizio L; Zuco C; Maniscalco GT; Soldani F; Monaco S; Trinka E; Hoeftberger R; Mariotto S
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1145-1153. PubMed ID: 32859745
[TBL] [Abstract][Full Text] [Related]
37. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J;
Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua.
Takahashi Y; Mori H; Mishina M; Watanabe M; Fujiwara T; Shimomura J; Aiba H; Miyajima T; Saito Y; Nezu A; Nishida H; Imai K; Sakaguchi N; Kondo N
Neurology; 2003 Oct; 61(7):891-6. PubMed ID: 14557555
[TBL] [Abstract][Full Text] [Related]
39. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.
Lai M; Hughes EG; Peng X; Zhou L; Gleichman AJ; Shu H; Matà S; Kremens D; Vitaliani R; Geschwind MD; Bataller L; Kalb RG; Davis R; Graus F; Lynch DR; Balice-Gordon R; Dalmau J
Ann Neurol; 2009 Apr; 65(4):424-34. PubMed ID: 19338055
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of gephyrin and GABAA receptor subunits during epileptogenesis in the CA1 region of hippocampus.
González MI; Cruz Del Angel Y; Brooks-Kayal A
Epilepsia; 2013 Apr; 54(4):616-24. PubMed ID: 23294024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
